Tilray Brands Shares Have Slumped More Than 50% in 2026 as Investors Weigh Cannabis Legalization Odds

Tilray Brands (NASDAQ:TLRY) has continued a long slide in 2026, with the stock losing more than half of its value year to date. The decline extends a steep multi-year drawdown: shares are down well over 95% over the past five years, according to a report published September 15, 2026.

The Canadian-American company, which spans cannabis, beverage alcohol, and wellness products, has struggled to deliver sustained profitability since cannabis was legalized in Canada in 2018. Persistent oversupply in the Canadian market, slower-than-hoped international expansion, and heavy acquisition activity have weighed on margins and shareholder returns. The 2026 selloff reflects continued pressure on the broader cannabis sector, where capital has remained scarce and regulatory catalysts have failed to materialize on schedules many market participants once expected.

The central variable for Tilray remains potential cannabis legalization in the United States. Even without federal reform on the near-term horizon, the company has positioned itself through U.S. acquisitions and brand licensing arrangements that could scale quickly if the regulatory landscape shifts. Proponents argue that Tilray’s diversified portfolio — including its growing craft beer and beverage business — provides a hedge while the cannabis industry awaits policy clarity. Skeptics point to the stock’s extreme volatility and multi-year erosion in shareholder value as evidence of the risk involved.

Tilray’s difficulties contrast with strength elsewhere in alternative-asset and consumer-facing public listings. Bullish (NYSE:BLSH), the cryptocurrency exchange operator, trades at $36.31, down 3.38% from its previous close of $37.58, with a market capitalization of approximately $5.51 billion — a reminder that speculative sectors across the market are seeing uneven investor appetite in 2026.

Analysts note that cannabis equities broadly remain sensitive to headlines from Washington, including rescheduling deliberations and state-level market developments. Any movement on those fronts has historically produced sharp, immediate swings in shares of companies like Tilray, regardless of near-term earnings fundamentals.

What to watch

• Tilray’s next quarterly earnings report and any updates on beverage-alcohol revenue growth versus cannabis segment performance.
• Federal cannabis rescheduling or legalization developments in the U.S., which have historically moved the stock sharply.
• Further state-level cannabis market openings or regulatory changes affecting U.S. operators.
• Any announcements regarding acquisitions, divestitures, or balance-sheet actions from Tilray management.

Source: original release